Castle Biosciences (CSTL) Profit After Tax Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) Profit After Tax Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 7.60% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -3.37% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -27.12% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 26.93% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 12.84% |
| 10 | Castle Biosciences | 919.57 Mn | 652.76 Mn | 79.85 Mn | -145.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -145.54% |
| Mar 31, 2026 | 43.82% |
| Dec 31, 2025 | -124.32% |
| Sep 30, 2025 | -122.08% |
| Jun 30, 2025 | -49.29% |
| Mar 31, 2025 | -920.05% |
| Dec 31, 2024 | 471.71% |
| Sep 30, 2024 | 132.86% |
| Jun 30, 2024 | 147.50% |
| Mar 31, 2024 | 91.32% |
| Dec 31, 2023 | 87.49% |
| Sep 30, 2023 | 65.90% |
| Jun 30, 2023 | -1,039.38% |
| Mar 31, 2023 | -18.60% |
| Dec 31, 2022 | -220.65% |
| Sep 30, 2022 | -71.73% |
| Jun 30, 2022 | 81.25% |
| Mar 31, 2022 | -475.30% |
| Dec 31, 2021 | -31.52% |
| Sep 30, 2021 | -156.94% |